Private Equity: Erst Opernabende, dann Anwälte: Der Machtkampf um die Med-Tech-Firma Brainlab eskaliert
Stefan Vilsmeier und der Finanzinvestor EMH wollten Brainlab an die Börse bringen. Jetzt fordert EMH Schadenersatz vom Gründer. Der will den größten Investor aus dem Aufsichtsrat werfen.
In a power struggle within the Med-Tech company Brainlab, investor Sebastian Kuss and founder Stefan Vilsmeier clashed over control of the company. The conflict escalated after Kuss' investment firm, EMH Partners, demanded Kuss recuse himself from leadership roles, accusing him of prioritizing his own interests over those of EMH.
Brainlab, a pioneer in software-assisted surgery, saw Vilsmeier as a co-owner with 50% of the company, while EMH held over a third. The dispute marked a dramatic turn from what could have been a German showcase story, with EMH now seeking a new buyer for its 35% stake in Brainlab, without the rights typically expected from a financial investor.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
